Autoimmune hepatitis after treatment with fluvastatin

Liver International

Volumn 27, Issue 4, 2007, Pages 592-

  Castiella, Agustin ^a   Fernandez, Javier ^a   Zapata, Eva ^a  

^a HOSPITAL DE MENDARO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; FLUINDOSTATIN;

ADD ON THERAPY; AGED; AUTOIMMUNE HEPATITIS; CASE REPORT; CORTICOSTEROID THERAPY; ECHOGRAPHY; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; LABORATORY TEST; LETTER; LIVER BIOPSY; MALE; OUTCOME ASSESSMENT;

AGED; ENZYME TESTS; FATTY ACIDS, MONOUNSATURATED; HEPATITIS, AUTOIMMUNE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; TRANSAMINASES;

EID: 34047236616     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01498.x     Document Type: Letter

References (6)

1. Noel B. Autoimmune disease and other potential side-effects of statins. Lancet 2004; 363: 2000.
2. Noel B. Risks and benefits of statins in lupus erythematosus. Arch Intern Med 2004; 164: 107-8.
3. Pelli N, Setti M, Ceppa P, Toncini C, Indiveri F. Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol 2003; 15: 921-4.
4. de Denus S, Spinler SA, Miller K, Peterson AM. Statins and liver toxicity: A meta-analysis. Pharmacotherapy 2004; 24: 584-91.
5. Gascon A, Zabala S, Iglesias E. Acute cholestasis during long-term treatment with fluvastatin in a nephrotic patient. Nephrol Dial Transplant 1999; 14: 1038.
6. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.